Skip to main content

Ligand Pharmaceuticals, Inc. (LGND) Insider Trading

In the last 90 days, 3 Ligand Pharmaceuticals, Inc. (LGND) insiders reported no open-market purchases and 7 sales totaling $6,585,411. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Nov 10, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Nov 10, 2026Jason AryehCorporate insiderSale3,000$320.05$960,141
Nov 4, 2026Jason AryehCorporate insiderSale282$319.99$90,237
Nov 2, 2026Andrew ReardonCLO & SecretarySale5,000$313.22$1,566,095
Nov 2, 2026Jason AryehCorporate insiderSale2,111$320.30$676,158
Oct 2, 2026Andrew ReardonCLO & SecretarySale5,000$304.07$1,520,346
Sep 10, 2026Martine ZimmermannCorporate insiderSale1,200$285.00$342,000
Sep 3, 2026Andrew ReardonCLO & SecretarySale5,000$286.09$1,430,435
Aug 12, 2026Octavio EspinozaChief Financial OfficerSale31,641$292.07$9,241,229
Aug 12, 2026Jason HaasCorporate insiderSale7,138$292.81$2,090,062
Aug 3, 2026Andrew ReardonCLO & SecretarySale5,000$288.99$1,444,951

Common questions

LGND insider trading FAQ

Are LGND insiders buying or selling?
Over the last 90 days, LGND insiders were net sellers, reporting $0.00 of open-market purchases and $6,585,411 of sales.
When was the last LGND insider purchase?
No open-market insider purchase of Ligand Pharmaceuticals, Inc. stock was reported in the last 90 days.
Where does LGND insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Ligand Pharmaceuticals, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.